Purchase Order W81K0221P0165
- Not listed
- The Defense Health Agency awarded a purchase order to Hamamatsu / Queen's Pet Imaging Center, LLC on October 1, 2024, for Fluorine 18 Fluorodeoxyglucose (FDG-18), a Positron Emission Tomography radiopharmaceutical, with a ceiling value of $3,496,038.46 and a firm fixed price. The order is not set-aside and originated from a sources-sought notice posted July 17, 2024. Performance takes place in Honolulu, Hawaii, where the radiopharmaceutical will be delivered to the Department of Nuclear Medicine...
- The Department of the Army Medical Command awarded a firm-fixed-price purchase order to Hamamatsu / Queen's Pet Imaging Center, LLC, a for-profit limited liability company, to provide Fluorine 18 Fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) radiopharmaceutical to the Tripler Army Medical Center (TAMC) in Honolulu, Hawaii. The contract, valued at $1,025,676.60, was awarded on October 1, 2019 with a completion date of September 30, 2021. The procurement was not set aside for any...
- <p>This federal contract award was made by the Medical Command (MEDCOM) of the U.S. Department of Defense to Hamamatsu / Queen's Pet Imaging Center, LLC, a for-profit limited liability company located in Honolulu, Hawaii. The contract, valued at $1,264,759.60, is for the F-18 FDG product and has a firm fixed price. The contract has an ultimate completion date of September 30, 2019 and was awarded on October 1, 2016. The contract does not have a set-aside designation.</p>
- The Defense Health Agency awarded a purchase order to Trillamed LLC on April 22, 2022, for radiopharmaceuticals including Fluorodeoxyglucose F-18 (FDG), Sodium Fluoride F-18 (NAF), and Fluorine-18 (F-18), with a ceiling value of $199,999.42. Trillamed is a Service-Disabled Veteran-Owned Small Business. Performance occurs at Bingham Farms, Michigan. The order carries firm fixed-price terms and an ultimate completion date of September 30, 2023. The procurement was issued under a solicitation...
- The Defense Health Agency awarded a $163,181.72 firm fixed-price delivery order to Lantheus Medical Imaging, Inc. for the provision of thirty-nine TechneLite MO99/TC99M technetium-99m generators at Tripler Army Medical Center in Hawaii. The delivery order was issued on October 1, 2023, with an ultimate completion date of September 30, 2024. This award was executed without a small business set-aside designation and represents a task order against Lantheus Medical Imaging's $6.5 million blanket...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED) of the U.S. Navy for the provision of radiopharmaceuticals used in positron emission tomography (PET) and computed tomography (CT) medical imaging procedures. The products to be delivered include fluorodeoxyglucose (FDG), sodium fluoride F-18 (NaF), Axumin (fluciclovine F-18), and Amyvid (florbetapir F-18). The contract has a ceiling value of $249,000.00 and a period of performance through January...
- The Defense Health Agency awarded a $150,035 firm fixed-price purchase order to Trillamed LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB) headquartered in Bingham Farms, Michigan, for the procurement of new F-18 Fludeoxyglucose unit doses and related radiopharmaceutical supplies. The contract, set aside exclusively for small businesses, was awarded on July 6, 2021, with performance at Fort Gordon, Georgia, and an ultimate completion date of July 5, 2026. The solicitation, posted on...
- The Department of Veterans Affairs (VA) awarded a $110,450.84 firm fixed price purchase order to Trillamed LLC, a service-disabled veteran-owned small business, for the supply of radiopharmaceuticals F18-Flurodeoxyglucose (FDG), F18-Sodium Flouride (NaF), and F18-Amyloid to the VA Northern California Health Care System. This award was made under a full and open competition with no set-aside designation. The contract has a period of performance through September 30, 2023. Trillamed is an...
- This is a $196,947.70 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Petnet Solutions, Inc., a subsidiary of the global technology conglomerate Siemens Aktiengesellschaft. The contract is for the supply of various radiopharmaceutical products, including fluorodeoxyglucose (FDG), Axumin, Amyvid, and Tauvid, to support the Department of Radiology Nuclear Medicine Services at Madigan Army Medical Center (MAMC) in Tacoma, Washington. The contract was awarded...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and products. The contract is for the supply of TECHNELITE GENERATOR M099/TC99M, 7500MC equipment to the Tripler Army Medical Center in Hawaii. The total potential value of the contract is $53,347.87, with a completion date of September 30, 2023. The contract is issued under the Pharmaceuticals and Drugs (FSS-61-IB)...
The Defense Health Agency awarded a firm fixed-price purchase order to Hamamatsu / Queen's Pet Imaging Center, LLC for the supply of Fluorine 18 Fluorodeoxyglucose (F-18 FDG), a positron emission tomography radiopharmaceutical, to Tripler Army Medical Center (TAMC) in Honolulu, Hawaii. The contract, valued at $1.47 million with an ultimate completion date of September 30, 2024, was awarded on October 1, 2021, following a pre-solicitation notice posted in July 2021. No set-aside designation was used in this procurement. The requirement called for a qualified vendor capable of providing F-18 FDG on an as-needed basis with rapid shipping capabilities to accommodate the radiopharmaceutical's limited shelf-life for use by TAMC's Department of Radiology. The award was modified in FY24 to provide additional funding for continued supply of this critical medical imaging agent. Tripler Army Medical Center, as a major Department of Defense medical facility, utilizes positron emission tomography imaging for oncology, neurology, and cardiology applications in support of military beneficiary care and treatment. The Defense Health Agency's procurement of this specialized pharmaceutical demonstrates the importance of maintaining reliable supply chains for advanced diagnostic capabilities at military medical treatment facilities.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Fludeoxyglucose 18 | W81K0221Q0166 | Department of the Army Medical Command | Pre-Solicitation 2/3 | 8/6/21, 11:33 AM | |
Fluedeoxyglucose 18 | W81k0221Q0166 | Department of the Army Medical Command | Pre-Solicitation 1/3 | 7/1/21, 11:19 AM | |
FDG-18 | W81K0221Q0166 | Department of the Army Medical Command | Award Notice 3/3 | 9/1/21, 7:11 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00009 | Supplemental Agreement for work within scope | ($243k) | 9/4/24 | |
| P00008 | Supplemental Agreement for work within scope | ($485k) | 3/27/24 | |
| P00007 | Funding Only Action | $573.4k | 10/6/23 | |
| P00006 | Exercise an Option | $0 | 8/8/23 | |
| P00005 | Funding Only Action | $545.5k | 10/28/22 |